From Name:
From Email:
To Name:
To Email:

Optional Message:

Startup Focuses on Drug That Prevents Iron Absorption Into the Body

from The University of Kansas

Bond Biosciences, a new startup based on research done at the University of Kansas, focuses on a new treatment for patients whose bodies absorb too much iron from the food they eat. The new technology is from the lab of Cory Berkland, a KU distinguished professor with dual appointments in pharmaceutical chemistry and chemical and petroleum engineering. His research focuses on ways to more effectively deliver drugs to their intended treatment targets in the body. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063